GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome

@article{Karim2018GNQ209PMI,
  title={GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome},
  author={N. Abdel Karim and Ihab Eldessouki and Ahmad Taftaf and Deeb Ayham and O. Gaber and Abouelmagd Makramalla and Z. Corr{\^e}a},
  journal={Case Reports in Oncological Medicine},
  year={2018},
  volume={2018}
}
  • N. Abdel Karim, Ihab Eldessouki, +4 authors Z. Corrêa
  • Published 2018
  • Medicine
  • Case Reports in Oncological Medicine
  • Metastatic prognosis in uveal melanoma is assessed by gene expression profiling (GEP) testing of the tumor cells, usually obtained by fine needle aspiration (FNA). GEP has demonstrated high accuracy in distinguishing class I and II tumors, both having different metastatic potential. Transcriptomic studies identified distinct mutations including somatic mutations in GNAQ and GNA11, detected in more than 80%, and contribute to the upregulation of the mitogen-activated protein kinase (MAPK… CONTINUE READING
    6 Citations
    Retrospective Study of the Effect of Statins on the Outcome of Lung Cancer Patients, University of Cincinnati Experience
    • 2
    • PDF
    Targeting Mutant KRAS for Anticancer Therapy.
    • 3
    Molecular and genetic diversity in melanoma of eye
    • PDF

    References

    SHOWING 1-10 OF 31 REFERENCES
    Oncogenic mutations in GNAQ occur early in uveal melanoma.
    • 276
    • PDF
    Mutations in GNA11 in uveal melanoma.
    • 745
    • Highly Influential
    Biology of advanced uveal melanoma and next steps for clinical therapeutics
    • 69
    Molecular Pathways Mediating Liver Metastasis in Patients with Uveal Melanoma
    • 130
    • PDF
    A Case Study in Advanced Lung Cancer Patients with Vimentin Over Expression.
    • 11
    Nab-paclitaxel in patients with metastatic melanoma
    • 8